Lidocaine Hcl And Epinephrine

   
Google
 
Web NewDrugInformation.com

Lidocaine Hcl And Epinephrine


Drug - Lidocaine Hcl And Epinephrine
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Epinephrine; Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.005MG/ML;1.5%
The potency of the active ingredient(s), Epinephrine; Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Lidocaine Hcl And Epinephrine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088571
The FDA assigned number to Lidocaine Hcl And Epinephrine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lidocaine Hcl And Epinephrine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 13, 1985
The date Lidocaine Hcl And Epinephrine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lidocaine Hcl And Epinephrine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lidocaine Hcl And Epinephrine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Lidocaine Hcl And Epinephrine.

Lidocaine Hcl And Epinephrine